about
Structuprint: a scalable and extensible tool for two-dimensional representation of protein surfaces.Silencing motifs in the Clr2 protein from fission yeast, Schizosaccharomyces pombeTheoretical study of the Usutu virus helicase 3D structure, by means of computer-aided homology modellingDirected evolution of Tau class glutathione transferases reveals a site that regulates catalytic efficiency and masks co-operativityAn integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonucleaseSpace constrained homology modelling: the paradigm of the RNA-dependent RNA polymerase of dengue (type II) virus.Current state-of-the-art molecular dynamics methods and applications.On integrating multi-experiment microarray data.Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.Gromita: a fully integrated graphical user interface to gromacs 4Hepatopulmonary hydatidosis in a ten-year-old girl: a case reportState-of-the-art technology in modern computer-aided drug design.Structural models for the design of novel antiviral agents against Greek Goat Encephalitis.Computational Construction of Antibody-Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable LinkerDesign, synthesis and application of benzyl-sulfonate biomimetic affinity adsorbents for monoclonal antibody purification from transgenic corn.A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase.Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.Molecular dynamics simulations through GPU video games technologies.3D structural analysis of proteins using electrostatic surfaces based on image segmentation3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological TargetGenetic and structural study of DNA-directed RNA polymerase II of Trypanosoma brucei, towards the designing of novel antiparasitic agents.Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.Investigating the structural stability of the Tup1-interaction domain of Ssn6: evidence for a conformational change on the complex.Antibodies as stratagems against cancer.An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.Protein signatures using electrostatic molecular surfaces in harmonic space.Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target.A splice variant of the human phosphohistidine phosphatase 1 (PHPT1) is degraded by the proteasome.Antibody Drug Conjugate bioinformatics: drug delivery through the letterboxAutomatic single- and multi-label enzymatic function prediction by machine learning.Erratum to: Structuprint: a scalable and extensible tool for two-dimensional representation of protein surfaces.A comprehensive phylogenetic analysis of deadenylases.Molecular modelling study of the 3D structure of the bovine viral diarrhea virus (BVDV) helicase.DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit.Phosphorylation of the arginine/serine repeats of lamin B receptor by SRPK1-insights from molecular dynamics simulations.3D molecular modeling and evolutionary study of the Trypanosoma brucei DNA Topoisomerase IB, as a new emerging pharmacological target.Introducing Drugster: a comprehensive and fully integrated drug design, lead and structure optimization toolkit.Kinetic and in silico analysis of the slow-binding inhibition of human poly(A)-specific ribonuclease (PARN) by novel nucleoside analogues.Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.Insights into the molecular mechanisms of stress and inflammation in ageing and frailty of the elderly.
P50
Q27309136-25A0D5F2-8BD0-495B-A52C-41C55EF3CA50Q27327527-CD265178-351A-4CC6-9857-B272161872F6Q27488875-A5136CB1-6ED6-47A5-8D7B-A2B06FBF9E6DQ27703096-7F370FFD-29FB-4BAB-A56D-4E8C27C61545Q28485501-3239D3CB-E7F9-40A9-8A61-49FF047E4666Q30353239-A55F65BB-1364-49AC-A927-A45EC91167A0Q30360202-BFA7977F-95FB-45B5-9537-D84BAAA70677Q30805789-81977ECB-50F5-4F3B-97DE-D4F5C0C2A324Q33438777-5B149D9C-E2B0-4D5C-8BCB-E0EC4791E56EQ33597646-E383C1F4-E55F-42A6-85FA-6A97BAD5FDCFQ34020012-5919FC71-9A98-47A2-8DD9-D064CE759844Q34475465-4E35F7DF-5165-456E-BE3D-18BB2EF65A54Q34483788-75367DD0-3527-4376-9291-D4F0C5490FC4Q34663010-2AA81D93-14EE-4193-8906-1E98E1A53783Q35077349-F16FCAFE-EDDA-4E1A-8AAF-4A7B8FDCB933Q36822284-8F34E832-901F-4DA5-BF22-ECDAD08E0C8AQ36870444-2C9CFEAE-0A21-4EDD-B204-795BD8FF72AEQ37165551-E564A0CD-D07E-486B-A7A7-5B816EA3F014Q37168062-2FC1D384-CA91-487A-9C4C-90C233EF70E5Q37239857-44E07764-9676-4E60-87DF-733CBC30399EQ37679007-2AC3BF50-F204-482C-BB43-0215D0DF9FC0Q38290398-260D0792-6629-4D57-8605-FAADBFFB49EEQ38299971-C6A75B4B-E979-4433-B1E5-55B3D109786EQ38688747-57F268A6-39D9-4877-AE55-A4E77F44E73DQ40006922-4385B5D8-86CF-4878-9ACE-52502F888488Q40230250-1785684F-A328-4E50-960C-91184A9B6408Q40243959-D1BEF04A-0BDE-4AB9-BB49-5B262DF8FB12Q41755054-27E5EB47-57B4-4404-AB34-1C5F7AF28BA0Q41858314-D248835C-57DE-4AB0-823F-12AB57F480A8Q42293187-D442E7AB-D7FD-42DA-B0DC-0FB86D1909FAQ42546716-9DBDC767-C9F3-46D3-9B6C-DAD592157621Q42814554-69FE55A0-D618-48B9-9724-C3359E7C4298Q42986924-8E2AEC5B-8EFB-456E-ADA9-C0752B3A17CFQ43117452-BE941945-52B8-4B15-9117-403D552B7460Q43576416-ED2D9B16-027D-440F-BD5A-B114089B4F53Q43851147-00333AAB-A66A-400F-B329-1A17FCF9DE7EQ44190372-9A6DFF5C-1818-42C1-92EF-7E755105E7BBQ45006895-74C8579F-9238-4953-8718-5DD7B7894AC0Q45994761-A69FC533-5DC3-4B1E-877F-38E7AA38FCB3Q47550059-67AACF2A-9424-4DCB-8F11-495D97980AE5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dimitrios Vlachakis
@ast
Dimitrios Vlachakis
@en
Dimitrios Vlachakis
@es
Dimitrios Vlachakis
@nl
Dimitrios Vlachakis
@sl
type
label
Dimitrios Vlachakis
@ast
Dimitrios Vlachakis
@en
Dimitrios Vlachakis
@es
Dimitrios Vlachakis
@nl
Dimitrios Vlachakis
@sl
prefLabel
Dimitrios Vlachakis
@ast
Dimitrios Vlachakis
@en
Dimitrios Vlachakis
@es
Dimitrios Vlachakis
@nl
Dimitrios Vlachakis
@sl
P1053
O-4323-2018
P106
P1153
23096470700
P21
P31
P3829
P496
0000-0003-1823-6102